糖尿病合并高血压的内科临床治疗体会

Experience of Medical Clinical Treatment of Diabetes with Hypertension

目的对糖尿病合并高血压的内科临床治疗方法及其效果进行研究。方法选取2019年5月-2021年2月110例糖尿病合并高血压患者为实验对象。根据随机编号结果的奇偶性分为两组,每组55例。对照组及实验组接受常规降糖治疗。对照组患者降压治疗中采用氨氯地平+贝那普利治疗,实验组患者采用硝苯地平缓释片+卡托普利治疗,分析和对比两组患者不良反应出现情况、收缩压及舒张压、治疗费用。结果对照组不良反应发生率为9.09%,实验组不良反应发生率为10.91%,组间数据相比差异较为微小(P>0.05)。对照组收缩压及舒张压为(140.5±18.4)mmHg、(82.6±10.2)mmHg,实验组收缩压及舒张压为(139.5±12.1)mmHg、(79.8±9.7)mmHg,组间数据相比差异较为微小(P>0.05);实验组患者治疗费用为(1642.4±103.5)元,对照组患者治疗费用为(2267.1±132.6)元,组间数据相比后者较高,差异有统计学意义(P<0.05)。结论在糖尿病合并高血压患者治疗过程中,硝苯地平缓释片+卡托普利、氨氯地平+贝那普利的应用效果不存在显著差异,但硝苯地平缓释片+卡托普利的治疗费用较低,医护人员在工作中应加以推广,以此减轻患者家庭的经济负担。

Objective To study clinical curative methods and effect of diabetes with hypertension.Methods The paper chose 110 patients with diabetes and hypertension from May 2019 to February 2021 as experimental subjects,and divided them into two groups according to parity of random numbering results,55 cases in each group.Control group and experimental group was treated with routine hypoglycemic therapy.Control group was treated with amlodipine+benazepril,and experimental group with nifedipine sustained-release tablets+captopril.Adverse reactions,systolic and diastolic blood pressures,and treatment cost between two groups was analyzed and compared.Results Incidence of adverse reactions in control group was 9.09%,and that in experimental group was 10.91%.There was little difference between two groups(P>0.05).Systolic and diastolic blood pressure in control group was(140.5±18.4)mmHg and(82.6±10.2)mmHg,while that in experimental group was(139.5±12.1)mmHg and(79.8±9.7)mmHg.Difference between two groups was small(P>0.05);treatment cost of experimental group was(1642.4±103.5)yuan,and that of control group was(2267.1±132.6)yuan.Data between groups was higher than the latter,with statistically significant difference(P<0.05).Conclusion In treatment of diabetes with hypertension,there is no significant difference between nifedipine sustained-release tablets+captopril and amlodipine+benazepril,but treatment cost of nifedipine sustained-release tablets+captopril is lower,medical staff should promote it in work to reduce economic burden of patients'families.